Minister of Health Budi Gunadi Sadikin appreciated the presence of the global biopharmaceutical company, Takeda, for organizing the Joint Steps to Prevent Dengue campaign to increase awareness and encourage active community participation in preventing dengue hemorrhagic fever (DHF).
“The Ministry of Health also supports dengue vector control with Wolbachia mosquito technology which is currently being implemented pilot project in six cities, namely Bali, Bandung, Jakarta, Semarang, Kupang and Bontang,” he said in a welcoming video for a dengue fever discussion event in Jakarta, Sunday.
He ensured that handling dengue fever was also carried out by involving the community, especially with the 3M Plus movement, namely Draining, Covering and Recycling used goods, as well as preventing mosquito bites and breeding.
“Now the Ministry of Health also welcomes the dengue vaccine innovation which can now be accessed by the wider community,” added Minister Budi.
Until the 33rd week of 2023, there were 57,884 cases of dengue fever recorded, with an incidence rate of 21.06 per 100,000 population. And 422 deaths with a death rate of 0.73 percent.
In efforts to prevent dengue fever, Takeda has established strong partnerships with stakeholders, including through a Cooperation Agreement with the Ministry of Health. The Ministry of Health’s efforts, especially the 2021-2025 National Dengue Management Strategy, reflect a serious commitment to overcoming dengue fever.
On that occasion, President Director of PT Takeda Innovative Medicines Andreas Gutknecht expressed his gratitude for the trust of the Indonesian government in making a commitment to achieve zero deaths from dengue fever by 2030.
“Takeda remains committed to playing an active role in fighting dengue fever as one of the founders of KOBAR (Joint Coalition Against Dengue) from the innovator sector,” he said.
Meanwhile, Director of Prevention and Control of Infectious Diseases, Ministry of Health, Dr. Imran Pambudi emphasized that dengue fever cases remain a serious threat to Indonesian society, especially with the El Nino phenomenon.
“Through the 2021-2025 National Dengue Management Strategy, the government has set an ambitious target to reduce dengue cases to less than 10 per 100,000 population by 2024, towards zero deaths by 2030,” said Dr. Imran.
He also reminded that everyone is at risk of dengue fever, regardless of their age, where they live or their lifestyle. This is why comprehensive protection, including the Ayo 3M Plus campaign and the DHF Vaccine, is so important in the government’s efforts to protect the public.
In Indonesia, dengue fever continues to be a significant disease burden in many regions. Three out of four deaths due to dengue mostly occur in children aged 0 to 14 years.
In line with global targets zero dengue death (which was launched) in 2021, the Ministry of Health has prepared a National Strategy for Controlling Dengue Disease, one of which is by administering vaccines.
The POM has given permission to distribute the DHF vaccine for use at ages 6 to 45 years. It is hoped that giving vaccines can be an important step to prevent and reduce serious risks in children, considering that there is no specific treatment for dengue fever.
DHF vaccination is clinically effective in reducing the incidence of dengue fever which can occur repeatedly in both children and adults as well as reducing the level of severity which will reduce the rate of hospitalization and death.
Also read: Adults of productive age are at risk of contracting dengue fever
Also read: Malaysia reports six deaths due to dengue fever
Editor: Admin Antarakalbar
COPYRIGHT © ANTARA News West Kalimantan 2023
2023-11-05 13:20:10
#Minister #Health #appreciates #cooperation #Takeda #efforts #prevent #dengue #fever #ANTARA #News #West #Kalimantan
